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Targeted disruption of the gene encoding DNA ligase IV leads to
lethality in embryonic mice
Deborah E. Barnes*, Gordon Stamp†, Ian Rosewell*, Angela Denzel‡
and Tomas Lindahl*
DNA ligase IV is the most recently identified member of
a family of enzymes joining DNA strand breaks in
mammalian cell nuclei [1,2]. The enzyme occurs in a
complex with the XRCC4 gene product [3], an
interaction mediated via its unique carboxyl terminus
[4,5]. Cells lacking XRCC4 are hypersensitive to ionising
radiation and defective in V(D)J recombination [3,6],
implicating DNA ligase IV in the pathway of
nonhomologous end-joining (NHEJ) of DNA double-
strand breaks mediated by XRCC4, the Ku70/80
heterodimer and the catalytic subunit of DNA-
dependent protein kinase (DNA-PKcs) in mammalian
cells (reviewed in [7]). The phenotype of a null mutant
of the Saccharomyces cerevisiae DNA ligase IV
homologue indicates that the enzyme is non-essential
and functions in yeast NHEJ [8–10]. Unlike other
mammalian DNA ligases for which cDNAs have been
characterised, DNA ligase IV is encoded by an
intronless gene (LIG4). Here, we show that targeted
disruption of LIG4 in the mouse leads to lethality
associated with extensive apoptotic cell death in the
embryonic central nervous system. Thus, unlike
Ku70/80 and DNA-PKcs [11–14], DNA ligase IV has an
essential function in early mammalian development.
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Results and discussion
We have used homologous recombination in embryonic
stem (ES) cells to investigate the effects of the DNA
ligase IV null mutation in the mouse. A lambda phage
clone containing the LIG4 gene was isolated from a mouse
129SV genomic library (Figure 1a). Partial DNA sequenc-
ing of the genomic clone revealed that the mouse LIG4
gene does not contain any introns. Amino acids 205–521,
which define the highly conserved catalytic domain of the
protein [1], are 91% identical between mouse and man;
the corresponding region of the human DNA ligase I
coding sequence is interrupted by nine introns of average
size 1.9 kb [15]. The DNA sequence encoding amino
acids 142–685 of the 911-residue DNA ligase IV [10] was
replaced in the targeting construct (Figure 1b,c).
G418-resistant clones arising from transfection of ES cells
with the targeting construct were screened for homologous
recombination at one allele of the LIG4 locus (Figure 1d).
Two independent ES clones (one from each of two sub-
strains of 129SV ES cells [16]) were injected into
C57BL/6J blastocysts to generate germline chimaeras and
lig4 mutant mice and gave analogous results in all subse-
quent experiments (Table 1). Mice heterozygous for the
targeted lig4 gene disruption were established from
germline chimaeras and these were phenotypically normal
up to 9 months of age. When F1 heterozygotes were inter-
bred, however, no offspring homozygous for the lig4 muta-
tion were detected in F2 litters. Cumulative genotyping of
104 liveborn mice from heterozygous intercrosses indi-
cated that lig4+/– and wild-type mice were recovered at a
ratio close to 2:1 (Table 1). Staged heterozygote matings
were analysed at embryonic stage E9.5 (days post-coitum;
Figure 1e) and lig4–/– embryos were recovered at frequen-
cies consistent with Mendelian segregation; these
embryos were visually indistinguishable from their wild-
type and heterozygous siblings. Live lig4–/– embryos were
still detected at E13.5 but not at E16.5 (Table 2). These
results indicate an essential function for the LIG4 gene
that results in a loss of viability two-thirds of the way
through mouse embryogenesis. 
Histopathological examination of E13.5 lig4–/– embryos
showed normal morphology of most organs. In each of four
lig4–/– E13.5 embryos from two different litters, however,
regions of the central nervous system (CNS) showed abnor-
mal pathology, with extensive apoptotic cell death
(Figures 2,3). Some apoptosis was also observed in the
spleen, at a higher level than in control embryos. In the
brain, apoptosis was most marked in the midbrain, around
the pons and the medulla, and also in the thalamus, hypo-
thalamus and striatum, with clusters of apoptotic cells and
loss of neurons leading to hypocellular regions. Intrigu-
ingly, the apoptotic clusters were symmetrical, clearly
affecting corresponding areas (Figure 3a,c). There was
extensive apoptosis in the mantle layer of the spinal cord,
but considerably less in the ependymal and marginal layers.
The olfactory lobes and epithelium appeared relatively
unaffected, as were the choroid plexus and meninges.
Focal apoptosis was seen in the peripheral zone of the
neopallial cortex, and also in the trigeminal ganglion and
other paravertebral ganglia. Five wild-type and heterozy-
gous siblings showed essentially normal development.
In S. cerevisiae, in contrast to mammalian cells, NHEJ is a
minor pathway for the repair of DNA double-strand breaks.
Yeast lig4-null mutants are deficient in NHEJ but are viable
[8–10], having a similar phenotype to mutants of the
recently discovered XRCC4 homologue, LIF1 [17]. One of
the major functions of the XRCC4 homologue in yeast
appears to be stabilisation of DNA ligase IV, so one would
expect both XRCC4 and DNA ligase IV function to be
affected in an xrcc4 knockout mouse [17]. Recently, Alt and
coworkers [18] have obtained knockout mice defective in
DNA ligase IV. This group independently observed the
embryonic lethal phenotype, and cell lines derived from null
embryos were deficient in V(D)J joining and hypersensitive
to ionising radiation [18]; this phenotype is very similar to
that previously observed for human xrcc4-mutant cells. 
As reported for DNA-PKcs [19], and possibly indicative of
differences in NHEJ between rodent and human cells
[20], DNA ligase IV and XRCC4 seem to be present at
extremely low levels in murine cell extracts and are not
readily detected by immunoblotting with various antisera
raised against the human proteins (R.P. Bowater and
D.E.B., unpublished observations). DNA ligase IV could
be detected in extracts from normal E13.5 mouse
embryos, however, by formation of a 32P-labelled
enzyme–AMP intermediate following co-immunoprecipi-
tation with antibodies against full-length recombinant
human XRCC4 [4]. As observed previously, most of the
DNA ligase IV was apparently adenylated in vivo, so radi-
olabelled enzyme–AMP was detected only following the
discharging of pre-formed complexes by incubation of the
co-immunoprecipitate with pyrophosphate [2]. No DNA
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Figure 1
Targeted disruption of the murine DNA ligase
IV locus. (a) Physical map of the lambda
genomic clone containing the LIG4 gene. The
locations of active site and 5′ flanking probes
are indicated, along with genomic fragments
that were subcloned to generate the targeting
construct. (b) Targeting construct containing
the selectable neomycin-resistance marker
gene (NEO). (c) The targeted DNA ligase IV
locus. (d) Representative lig4 heterozygous
ES clone showing homologous recombination
at one allele of the LIG4 gene. (e) Genotyping
of E9.5 LIG4 wild-type (+/+), lig4
heterozygous (+/–) and lig4 homozygous (–/–)
embryos. (f) Absence of functional DNA ligase
IV in lig4-null embryos. (a–c) Restriction
enzyme sites are abbreviated as follows: B,
BamHI; E, EcoRI; H, HindIII; N, NotI; S, SacI.
Sites shown in red were used to orientate
genomic fragments in the targeting construct.
Genomic sequences are denoted by a thin
line, the DNA ligase IV open reading frame by
a thick line, and vector sequences by a dashed
line. Arrows indicate the location of primers
used to genotype embryos by PCR (see
Materials and methods). A restriction digest
with BamHI gives rise to a ~13 kb fragment at
the wild-type locus that is detected by
hybridisation with both the 5′ flanking and
active site probes (a,d), whereas the targeted
allele produces a ~8 kb BamHI fragment that
is detected by the 5′ flanking probe only (c–e).
(f) DNA ligase IV (arrow) was co-
immunoprecipitated from extracts of normal or
lig4-null E13.5 embryos with XRCC4-specific
antiserum, and adenylated with [α-32P]ATP
following pre-incubation with (+) or without (–)
0.5 mM sodium pyrophosphate (PPi).
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Table 1
Genotyping of liveborn progeny from intercrosses of
heterozygous lig4 mice.
Source Number Average Genotype No
of litters litter size (+/+) (+/–) (–/–) result
R1 8 5.1 16 25 0 –
GK129 8 8.1 19 44 0 2
Total 35 69 0
ligase IV activity was detected in E13.5 lig4-null embryos
(Figure 1f).
DNA ligase IV is implicated in NHEJ in mammalian cells
[4,5] and carries out the ligation step of NHEJ in vitro
[20,21]. Mutant mammalian cell lines deficient in the
XRCC4, Ku70, Ku80 or DNA-PKcs components of the
NHEJ pathway are also defective in V(D)J recombination
(reviewed in [7]). Of the gene products proposed to act in
NHEJ in mammalian cells, only DNA ligase IV has not
been represented amongst previously described mutant
cell lines [22]. Here, genetic studies of this enzyme in
mammalian cells were initiated by targeted disruption of
the gene encoding DNA ligase IV in mice. Unlike null
mutations affecting other components of the NHEJ
pathway, such as DNA-PKcs and Ku70/80 [11–14], the
lig4-null mutation leads to embryonic lethality in the
mouse. The possibility that this phenotype could be
ascribed to the loss of a different overlapping gene is
highly unlikely but cannot at present be excluded. Future
analyses will aim to determine the unanticipated essential
function of DNA ligase IV that is limiting during differen-
tiation of the embryonic CNS. Murine lig4-null cells may
exhibit an inadequate response to growth regulatory
signals, as described for the yeast lig4 mutant [17], and this
defect might have particularly severe consequences in
developing neural tissue. Alternatively, the high level of
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Figure 2
Abnormal CNS development in lig4-null embryos. (a) A section from
the mid-spinal cord of an E13.5 lig4-null embryo with the ependymal
layer lining the central canal relatively unaffected (arrowhead), but
numerous scattered and clustered apoptotic bodies in the mantle layer
(large arrows). Intercellular spaces are more apparent because of cell
loss (small arrows). Sections were stained with haematoxylin and eosin
and examined at original magnification ×400. (b) A corresponding area
in a wild-type embryo shows the expected cellularity; no apoptotic
bodies are seen.
(a)
(b)
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Table 2
Genotyping of embryos from staged matings of heterozygous
lig4 mice.
Embryo Number Average Genotype Total
stage of litters litter size (+/+) (+/–) (–/–)
E9.5 5 8.4 11 20 11 42
E10.5 4 5.8 5 14 4 23
E11.5 3 9.7 8 13 8 29
E13.5 3 7.3 6 14 2 22
E15.5 1 – 0 2 0 2
E16.5 1 – 1 3 1* 7†
*The lig4–/– embryo had died by ~E15.5. †Includes two resorptions
that could not be genotyped by PCR.
Figure 3
TUNEL analysis (terminal deoxynucleotide transferase mediated dUTP
nick end labelling). (a) A coronal section through the brain of an E13.5
lig4-null embryo (the arrow indicates the third ventricle). Clusters of
apoptotic cells are highlighted by TUNEL labelling, revealing a
symmetrical distribution. TUNEL immunoperoxidase; original
magnification ×40. (b) Strong TUNEL labelling (arrows) of the
clustered nuclear debris seen in Figure 2a, confirming apoptosis;
original magnification ×400. (c,d) The medulla oblongata region shows
symmetrical distribution of apoptotic clusters (arrows) in a lig4-null
embryo (c) with no labelling in a wild-type control (d); original
magnification ×250.
(a) (b)
(c) (d)
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oxygen metabolism in the brain might lead to the forma-
tion of reactive oxygen species that generate endogenous
DNA double-strand breaks at a higher frequency than in
other organs, and DNA ligase IV may be required to repair
such damage. The murine DNA ligase IV null phenotype
may also be relevant to a possible role of somatic DNA
recombination in the development of the CNS [23].
Materials and methods
Construction of the lig4 targeting vector
A partial murine cDNA clone encoding the catalytic domain of DNA
ligase IV was isolated by reverse transcription PCR and used to screen
a mouse 129SV genomic library in λ2001 [24] using standard tech-
niques. A genomic clone (~17 kb) was mapped for the restriction
enzymes shown in Figure 1, a ~1 kb HindIII fragment was identified as
containing the active site of the enzyme by hybridisation with a specific
oligonucleotide probe, and the entire DNA ligase IV open reading frame
was sequenced. A ~5.5 kb HindIII fragment 5′ to the active site was
cloned into the BamHI site of pSK-MC1–NEO–polyA [25] and a
~3.2 kb BamHI–EcoRI 3′ fragment was cloned into the XhoI site by
means of double-stranded oligonucleotide linkers; HindIII and XhoI sites
were not regenerated during this process (Figure 1). The targeting con-
struct was verified by restriction enzyme digest and DNA sequencing,
and propagated in the SURE Escherichia coli strain (Stratagene). 
Generation of lig4-mutant mice
NotI-linearised targeting vector was electroporated into GK129 or RI ES
cells [16] from 129SV mice and selected as described previously [25].
G418-resistant colonies were transferred into duplicate 96-well plates.
Genomic DNA was isolated from one set of plates, digested with BamHI
and analysed by Southern hybridisation analysis (Figure 1d). ES clones
in which homologous recombination had occurred in one allele of the
LIG4 gene were expanded from duplicate plates and injected into blas-
tocysts from C57BL/6J mice [25]. Resultant chimaeras were mated, and
agouti F1 progeny screened by tail biopsy. Mice heterozygous for the
targeted lig4 allele were interbred and F2 progeny genotyped as above. 
Analysis of lig4 embryos
Post-implantation embryos were explanted from pregnant females fol-
lowing staged heterozygous matings, with E0.5 corresponding to detec-
tion of a vaginal plug. Genotyping of embryos was carried out by PCR
amplification of DNA from the microdissected yolk sac after boiling for
10 min in 20–100 µl distilled water. NEO and LIG4 gene-specific
primers (30-mers) were located as shown in Figure 1. PCR amplification
of genomic DNA was carried out for 30 cycles with primers F1, N1 and
R1, and one-tenth of the PCR product was further amplified for 30
cycles with nested primers F2, N2 and R2, producing a 1.6 kb fragment
from the wild-type allele and a 1.1 kb fragment from the targeted allele,
which were resolved by ethidium bromide/agarose gel electrophoresis.
Microdissected embryos were fixed in 10% saline formalin, embedded
in paraffin, and sections stained with haematoxylin and eosin. Apoptotic
regions were identified using the ApopTag kit (Oncor, Gaithersberg,
MD), essentially as described by the manufacturer but omitting the pro-
teinase K step. Extracts were prepared by macerating embryos in lysis
buffer, and immunoprecipitation and enzyme adenylation were carried
out as described previously [26]. SJ4 antiserum against XRCC4 was
provided by S. Jackson (Wellcome-CRC Institute, Cambridge, UK). 
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